These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26044701)

  • 1. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
    Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
    Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.
    Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A
    Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial.
    Moniche F; Cabezas-Rodriguez JA; Valverde R; Escudero-Martinez I; Lebrato-Hernandez L; Pardo-Galiana B; Ainz L; Medina-Rodriguez M; de la Torre J; Escamilla-Gomez V; Ortega-Quintanilla J; Zapata-Arriaza E; de Albóniga-Chindurza A; Mancha F; Gamero MA; Perez S; Espinosa-Rosso R; Forero-Diaz L; Moya M; Piñero P; Calderón-Cabrera C; Nogueras S; Jimenez R; Martin V; Delgado F; Ochoa-Sepúlveda JJ; Quijano B; Mata R; Santos-González M; Carmona-Sanchez G; Herrera C; Gonzalez A; Montaner J
    Lancet Neurol; 2023 Feb; 22(2):137-146. PubMed ID: 36681446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.
    Prasad K; Sharma A; Garg A; Mohanty S; Bhatnagar S; Johri S; Singh KK; Nair V; Sarkar RS; Gorthi SP; Hassan KM; Prabhakar S; Marwaha N; Khandelwal N; Misra UK; Kalita J; Nityanand S;
    Stroke; 2014 Dec; 45(12):3618-24. PubMed ID: 25378424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
    Schellinger PD; Alexandrov AV; Barreto AD; Demchuk AM; Tsivgoulis G; Kohrmann M; Alleman J; Howard V; Howard G; Alexandrov AW; Brandt G; Molina CA;
    Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.
    Battistella V; de Freitas GR; da Fonseca LM; Mercante D; Gutfilen B; Goldenberg RC; Dias JV; Kasai-Brunswick TH; Wajnberg E; Rosado-de-Castro PH; Alves-Leon SV; Mendez-Otero R; Andre C
    Regen Med; 2011 Jan; 6(1):45-52. PubMed ID: 21175286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNA after autologous bone marrow mononuclear cell (BM-MNC) injection in patients with ischemic stroke.
    Mancha F; Escudero-Martinez I; Zapata-Arriaza E; Vega-Salvatierra A; Cabezas JA; Lebrato L; Pardo B; De-La-Torre J; Zapata M; Escamilla V; Calderón-Cabrera C; Martín-Sánchez J; Valverde R; Aguera-Morales E; Herrera I; Delgado F; Gamero MÁ; Pérez-Sánchez S; Moya M; Espinosa R; Ortega-Quintanilla J; Gutierrez-Jarrin I; González-García A; Montaner J; Moniche F
    J Investig Med; 2020 Mar; 68(3):807-810. PubMed ID: 31852749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.
    Hess DC; Sila CA; Furlan AJ; Wechsler LR; Switzer JA; Mays RW
    Int J Stroke; 2014 Apr; 9(3):381-6. PubMed ID: 23692637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.
    Vahidy FS; Haque ME; Rahbar MH; Zhu H; Rowan P; Aisiku IP; Lee DA; Juneja HS; Alderman S; Barreto AD; Suarez JI; Bambhroliya A; Hasan KM; Kassam MR; Aronowski J; Gee A; Cox CS; Grotta JC; Savitz SI
    Stem Cells; 2019 Nov; 37(11):1481-1491. PubMed ID: 31529663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke.
    Friedrich MA; Martins MP; Araújo MD; Klamt C; Vedolin L; Garicochea B; Raupp EF; Sartori El Ammar J; Machado DC; Costa JC; Nogueira RG; Rosado-de-Castro PH; Mendez-Otero R; Freitas GR
    Cell Transplant; 2012; 21 Suppl 1():S13-21. PubMed ID: 22507676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
    Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
    Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
    Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.
    Brenneman M; Sharma S; Harting M; Strong R; Cox CS; Aronowski J; Grotta JC; Savitz SI
    J Cereb Blood Flow Metab; 2010 Jan; 30(1):140-9. PubMed ID: 19773802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial.
    Moniche F; Montaner J; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Cayuela A; Escudero I; de la Torre-Laviana FJ; Boada C; Rosell A; Mayol A; Jimenez MD; Gil-Peralta A; Gonzalez A
    Cell Transplant; 2014; 23 Suppl 1():S57-64. PubMed ID: 25335778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
    Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
    Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHIMES-I: sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study.
    Navarro JC; Chen CL; Lagamayo PD; Geslani MB; Eow GB; Poungvarin N; de Silva A; Wong LK; Venketasubramanian N;
    Int J Stroke; 2013 Aug; 8(6):491-4. PubMed ID: 23506216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset.
    Zivin JA; Sehra R; Shoshoo A; Albers GW; Bornstein NM; Dahlof B; Kasner SE; Howard G; Shuaib A; Streeter J; Richieri SP; Hacke W;
    Int J Stroke; 2014 Oct; 9(7):950-5. PubMed ID: 23013107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-Arterial Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Ischemic Stroke Patients.
    Hammadi AMA; Alhimyari F
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):239-241. PubMed ID: 30777565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
    Shichinohe H; Kawabori M; Iijima H; Teramoto T; Abumiya T; Nakayama N; Kazumata K; Terasaka S; Arato T; Houkin K
    BMC Neurol; 2017 Sep; 17(1):179. PubMed ID: 28886699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.